Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France

Coronavirus Infections Clinical Trial

— FRENCH ICU  

Official title:

Study of the Increase in ICU Beds Capacity and Caregivers During COVID-19 Pandemic in France : the FRENCH ICU Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04420286
• Other study ID #: 30RC20_0117
• Status: Completed
• Start date: May 6, 2020
• Est. completion date: June 12, 2020

Study information

• Verified date: August 2021
• Source: Centre Hospitalier Universitaire de Nimes
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

For preventing the overwhelming of ICU beds capacity during COVID-19 pandemic in France, national and regional Health-Care institutions decided to optimize the Intensive Care Unit beds availability by opening new ICU beds in institutions with and without prior ICU. The Present study was design to retrospectively describe the origin of the ICU beds and human resources created during the COVID-19 outbreak in France.

Description:

Since December 2019, the SARS-CoV-2 coronavirus disease has caused a worldwide outbreak of respiratory illness that rapidly invaded leading the world (WHO). Its most severe form is dominated by an acute respiratory distress syndrome (ARDS) with other organ failures requiring mechanical ventilation and admission in Intensive Care Unit (ICU). With a wide pandemic effect and a long length of mechanical ventilation, the intensive care units were quickly full.

For preventing the overwhelming of ICU beds capacity, national and regional Health-Care institutions (then French Health minister, every Regional Health) decided to optimize the Intensive Care Unit beds availability by opening new ICU beds in institutions with and without prior ICU.

Daily ICU beds availability was assessed in each institution, and at the regional level to organize potential patient transfers across regional and national hospital. Moreover, an extraordinary mobilization and joint efforts of medical, paramedical and administrative staff allowed getting the caregivers for managing the most severe patients in each ICU. All physicians who could manage ICU patients were involved in this crisis. In this context, anesthesiologists (who have gotten an ICU education during their studies) were involved, as the surgical activity has been reduced to the vital procedures. This overall organization permitted the admission of more patients than the initial maximum national capacity of ICU beds.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 9860
• Est. completion date: June 12, 2020
• Est. primary completion date: June 12, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Hospital having ICU during COVID-19 outbreak in France

Exclusion Criteria:

• Hospital refuse to participate

Related Conditions & MeSH terms

• Coronavirus Infections
• COVID19 Outbreak in France

Locations

Country	Name	City	State
France	CHU de Nîmes, Hôpital Universitaire Carémeau	Nimes

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	origin of the ICU beds created during the COVID-19 outbreak in France.	Describe the origin of the ICU beds created during the COVID-19 outbreak in France.	DAY 0
Secondary	Human Resources	Describe the human resources (medical and non-medical) mobilized to ensure that all acute patients could be managed (physicians according to their initial specialty, nurses and nursing auxiliaries).	DAY 0